Most Read News

Sales rise 6.67% to Rs 1.44 crore

Reported sales nil

Sales rise 9.09% to Rs 0.24 crore

Sales rise 0.79% to Rs 5.10 crore

Sales decline 54.88% to Rs 3.56 crore

Sales rise 48.01% to Rs 813.21 crore

Lupin intimated that they have entered into a license, supply and technology sharing agreement with Axantia Holding (Axantia), operating through its pharmaceutical subsidiaries - Pharma International Company and Med City Pharmaceutical Industries.

Reported sales nil

INR Settles Lower Post Budget The Indian rupee pared its initial gains and settled 17 paise lower at 74.82 (provisional) against US dollar on Tuesday on the back of higher-than-expected borrowing in the next financial year. The total Market Borrowings of the government for 2022-23 are estimated to stand at Rs. 11,58,719 crore. The Revised Estimates for the same for 2021-22 are Rs. 8, 75,771 […]

India benchmark government bond yields rose sharply in response to the higher-than-expected gross market borrowing numbers of the Union government. The total Market Borrowings of the government for 2022-23 are estimated to stand at Rs. 11,58,719 crore. The Revised Estimates for the same for 2021-22 are Rs. 8, 75,771 crore as against the Budget Estimates of Rs. 9, 67,708 crore. The 10-year 6.54 GS 2032 […]